Free Newsletter
Florida moves up the charts in tech spin-offs
BusinessWeek has discovered something that's been evident in the biotech community for some time: The University of Florida has made some amazing progress in turning its research projects into start-up companies. In the 2004 to 2005 time frame, Florida spun off 13 start-ups. That put it behind the big three of MIT, the University of California and the California Institute of Technology, but ahead of powerhouse centers like Johns Hopkins. Florida's licensing income has grown as well, up from $11 million 10 years earlier to $40.3 million. David Day, the main guy at Florida for technology transfer deals, says that their approach has been to keep the scientists in the lab while finding an experienced management team to handle the start-up. Florida has been a treasure trove of new discoveries in the life sciences, and the university's work is being complemented by new programs at the trio of research institutions that have set up Florida campuses.
- here's the report on Florida from BusinessWeek
Related Articles:
Florida gets an honorable mention, with a warning. Report
Can Florida woo biotechs? Report
Scripps Florida sees first biotech spin-off take root. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




